These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9825802)

  • 21. Hepatitis A antibody in Israel Defence Forces recruits.
    Kark JD; Bar-Shani S
    J Med Virol; 1981; 6(4):341-5. PubMed ID: 6264023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis A vaccines.
    Wkly Epidemiol Rec; 2000 Feb; 75(5):38-44. PubMed ID: 10693358
    [No Abstract]   [Full Text] [Related]  

  • 23. [Prevalence of anti-HAV antibodies in selected groups of children].
    Ryszkowska A; Gładysz A; Inglot M; Molin I
    Przegl Epidemiol; 2000; 54(3-4):375-83. PubMed ID: 11349601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hepatitis A virus immune status of Antilles military personnel: incidence after prophylaxis].
    Dulat C; Defrance JP; Ille H
    Med Trop (Mars); 1996; 56(3):255-8. PubMed ID: 9026592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rising hepatitis A immunity in U.S. military recruits.
    Nevin RL; Niebuhr DW
    Mil Med; 2007 Jul; 172(7):787-93. PubMed ID: 17691697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serological hepatitis A virus infections and ratio of clinical to serological infections in a controlled trial of pre-exposure prophylaxis with immune serum globulin.
    Kark JD; Bar-Shany S; Shor S; Merlinski L; Nili E
    J Epidemiol Community Health; 1985 Jun; 39(2):117-22. PubMed ID: 3891900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Current status and vaccine indication for hepatitis A virus infection in Korea].
    Jeong SH
    Korean J Gastroenterol; 2008 Jun; 51(6):331-7. PubMed ID: 18604134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The changing epidemiology of hepatitis A in Italy.
    Stroffolini T; D'Amelio R; Matricardi PM; Chionne P; Napoli A; Rapicetta M; Crateri S; Pasquini P
    Ital J Gastroenterol; 1993; 25(7):372-4. PubMed ID: 8280898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Seroprevalence of antibodies against hepatitis A (anti-HAV) in Singapore: the NFDD experience.
    Fock KM; Tay HH; Phua KB; Guan R; Chia SC; Chong R; Chee AE; Chew CN
    Singapore Med J; 1995 Feb; 36(1):26-7. PubMed ID: 7570129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association in the seroprevalence of hepatitis A and herpes simplex-1 viruses in young adults in Israel.
    Katz J; Gdalevich M; Ashkenazi I; Chaushu G; Shemer J
    Infection; 2000; 28(4):231-3. PubMed ID: 10961530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-HAV seroprevalence in German travellers and hepatitis A vaccination in immune subjects.
    Bienzle U; Bock HL; Meister W; Clemens R; Kruppenbacher JP
    Lancet; 1993 Apr; 341(8851):1028. PubMed ID: 8096914
    [No Abstract]   [Full Text] [Related]  

  • 32. Single dose-inactivated hepatitis A vaccination schedule for susceptible youngsters.
    Lee SD; Chan CY; Yu MI; Wang YJ; Lo KJ; Safary A
    Am J Gastroenterol; 1996 Jul; 91(7):1360-2. PubMed ID: 8677995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Should sewage workers and carers for people with learning disabilities be vaccinated for hepatitis A?
    Poole CJ; Shakespeare AT
    BMJ; 1993 Apr; 306(6885):1102. PubMed ID: 8388287
    [No Abstract]   [Full Text] [Related]  

  • 34. Cost-effective analysis of hepatitis A prevention in Ireland.
    Rajan E; Shattock AG; Fielding JF
    Am J Gastroenterol; 2000 Jan; 95(1):223-6. PubMed ID: 10638588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiologic shift in the prevalence of Hepatitis A virus in Saudi Arabia: a case for routine Hepatitis A vaccination.
    Almuneef MA; Memish ZA; Balkhy HH; Qahtani M; Alotaibi B; Hajeer A; Qasim L; Al Knawy B
    Vaccine; 2006 Jul; 24(27-28):5599-603. PubMed ID: 16757065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Vaccination against viral hepatitis A and B in adults aged over 40 years--antibody persistence and immune memory].
    Chlibek R; Smetana J; Bostíková V; Splino M
    Epidemiol Mikrobiol Imunol; 2011 Sep; 60(3):99-108. PubMed ID: 22132651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Protection of adolescents against hepatitis A].
    Puntarić D; Baklaić Z; Ljubicíc M; Vodopija I
    Lijec Vjesn; 1996 Oct; 118(10):241-3. PubMed ID: 9132523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of immune serum globulin in an outbreak of hepatitis A virus infection in adults.
    Green MS; Dotan K
    J Infect; 1988 Nov; 17(3):265-70. PubMed ID: 2851022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis A in Western Austria--the epidemiological situation before the introduction of active immunisation.
    Prodinger WM; Larcher C; Sölder BM; Geissler D; Dierich MP
    Infection; 1994; 22(1):53-5. PubMed ID: 8181844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adult infection with hepatitis A despite declining endemicity; in favor of adult vaccination.
    Gillis D; Grotto I; Mimouni D; Huerta M; Gdalevich M; Shpilberg O
    Vaccine; 2002 May; 20(17-18):2243-8. PubMed ID: 12009279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.